Combatting intracellular pathogens using bacteriophage delivery

References

• Adams KN, Takaki K, Connolly LE, Wiedenhoft H, Winglee K, Humbert O, Edelstein PH, Cosma CL, Ramakrishnan L. 2011. Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism. Cell. 145(1):39–53.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Johnson CT, Imhoff BR, Donlan RM, McCarty NA, García AJ. 2018. Inhaled bacteriophage-loaded polymeric microparticles ameliorate acute lung infections. Nat Biomed Eng. 2(11):841–849.
   PubMed Web of Science ®Google Scholar
• Ahamed ST, Roy B, Basu U, Dutta S, Ghosh AN, Bandyopadhyay B, Giri N. 2019. Genomic and proteomic characterizations of Sfin-1, a novel lytic phage infecting multidrug-resistant shigella spp. and Escherichia coli C. Front Microbiol. 10:1876–1876.
   PubMed Web of Science ®Google Scholar
• Ahmadi H, Barbut S, Lim L-T, Balamurugan S. 2020. Examination of the use of bacteriophage as an additive and determining its best application method to control listeria monocytogenes in a cooked-meat model system. Front Microbiol. 11(779):779.
   PubMedGoogle Scholar
• Amarh ED, Dedrick RM, Garlena RA, Russell DA, Jacobs-Sera D, Hatfull GF. 2021. Genome sequence of Mycobacterium abscessus Phage phiT46-1. Microbiol Resour Announc. 10(2):e01421–20.
   PubMed Web of Science ®Google Scholar
• Armstrong JA, Hart PD. 1971. Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes. J Exp Med. 134(3 Pt 1):713–740.
   PubMed Web of Science ®Google Scholar
• Azimi T, Mosadegh M, Nasiri MJ, Sabour S, Karimaei S, Nasser A. 2019. Phage therapy as a renewed therapeutic approach to mycobacterial infections: a comprehensive review. Infect Drug Resist. 12:2943–2959.
   PubMed Web of Science ®Google Scholar
• Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S, Romero DA, Horvath P. 2007. CRISPR provides acquired resistance against viruses in prokaryotes. Science. 315(5819):1709–1712.
   PubMed Web of Science ®Google Scholar
• Bastidas RJ, Elwell CA, Engel JN, Valdivia RH. 2013. Chlamydial intracellular survival strategies. Cold Spring Harb Perspect Med. 3(5):a010256.
   PubMed Web of Science ®Google Scholar
• Baudoux P, Bles N, Lemaire S, Mingeot-Leclercq M-P, Tulkens PM, Van Bambeke F. 2007. Combined effect of pH and concentration on the activities of gentamicin and oxacillin against Staphylococcus aureus in pharmacodynamic models of extracellular and intracellular infections. J Antimicrob Chemother. 59(2):246–253.
   PubMed Web of Science ®Google Scholar
• Beckman KB, Ames BN. 1997. Oxidative decay of DNA. J Biol Chem. 272(32):19633–19636.
   PubMed Web of Science ®Google Scholar
• Bertram C, Hass R. 2008. Cellular responses to reactive oxygen species-induced DNA damage and aging. Biol Chem. 389(3):211–220.
   PubMed Web of Science ®Google Scholar
• Bhattarai SR, Yoo SY, Lee S-W, Dean D. 2012. Engineered phage-based therapeutic materials inhibit Chlamydia trachomatis intracellular infection. Biomaterials. 33(20):5166–5174.
   PubMed Web of Science ®Google Scholar
• Brouillette E, Grondin G, Shkreta L, Lacasse P, Talbot BG. 2003. In vivo and in vitro demonstration that Staphylococcus aureus is an intracellular pathogen in the presence or absence of fibronectin-binding proteins. Microb Pathog. 35(4):159–168.
   PubMed Web of Science ®Google Scholar
• Broxmeyer L, Sosnowska D, Miltner E, Chacón O, Wagner D, McGarvey J, Barletta RG, Bermudez LE. 2002. Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent mycobacterium: a model for phage therapy of intracellular bacterial pathogens. J Infect Dis. 186(8):1155–1160.
   PubMed Web of Science ®Google Scholar
• Bryan D, El-Shibiny A, Hobbs Z, Porter J, Kutter EM. 2016. Bacteriophage T4 infection of stationary phase E. coli: life after log from a phage perspective. Front Microbiol. 7:1391.
   PubMed Web of Science ®Google Scholar
• Bus T, Traeger A, Schubert US. 2018. The great escape: how cationic polyplexes overcome the endosomal barrier. J Mater Chem B. 6(43):6904–6918.
   PubMed Web of Science ®Google Scholar
• Campoccia D, Montanaro L, Arciola CR. 2013. A review of the biomaterials technologies for infection-resistant surfaces. Biomaterials. 34(34):8533–8554.
   PubMed Web of Science ®Google Scholar
• Capparelli R, Parlato M, Borriello G, Salvatore P, Iannelli D. 2007. Experimental phage therapy against Staphylococcus aureus in mice. Antimicrob Agents Chemother. 51(8):2765–2773.
   PubMed Web of Science ®Google Scholar
• Carrigy NB, Larsen SE, Reese V, Pecor T, Harrison M, Kuehl PJ, Hatfull GF, Sauvageau D, Baldwin SL, Finlay WH, et al. 2019. Prophylaxis of Mycobacterium tuberculosis H37Rv infection in a preclinical mouse model via inhalation of nebulized bacteriophage D29. Antimicrob Agents Chemother. 63(12):e00871–19.
   Web of Science ®Google Scholar
• Carvalho C, Costa AR, Silva F, Oliveira A. 2017. Bacteriophages and their derivatives for the treatment and control of food-producing animal infections. Crit Rev Microbiol. 43(5):583–601.
   PubMed Web of Science ®Google Scholar
• Chadha P, Katare OP, Chhibber S. 2017. Liposome loaded phage cocktail: enhanced therapeutic potential in resolving Klebsiella pneumoniae mediated burn wound infections. Burns. 43(7):1532–1543.
   PubMed Web of Science ®Google Scholar
• Chhibber S, Kaur J, Kaur S. 2018. Liposome entrapment of bacteriophages improves wound healing in a diabetic mouse MRSA infection. Front Microbiol. 9:561.
   PubMed Web of Science ®Google Scholar
• Cinquerrui S, Mancuso F, Vladisavljević GT, Bakker SE, Malik DJ. 2018. Nanoencapsulation of bacteriophages in liposomes prepared using microfluidic hydrodynamic flow focusing. Front Microbiol. 9:2172.
   PubMed Web of Science ®Google Scholar
• Citorik RJ, Mimee M, Lu TK. 2014. Bacteriophage-based synthetic biology for the study of infectious diseases. Curr Opin Microbiol. 19:59–69.
   PubMed Web of Science ®Google Scholar
• Cogan NG. 2006. Effects of persister formation on bacterial response to dosing. J Theor Biol. 238(3):694–703.
   PubMed Web of Science ®Google Scholar
• Colom J, Cano-Sarabia M, Otero J, Aríñez-Soriano J, Cortés P, Maspoch D, Llagostera M. 2017. Microencapsulation with alginate/CaCO3: a strategy for improved phage therapy. Sci Rep. 7:41441.
   PubMed Web of Science ®Google Scholar
• Comeau AM, Tétart F, Trojet SN, Prère M-F, Krisch HM. 2007. Phage-Antibiotic Synergy (PAS): beta-lactam and quinolone antibiotics stimulate virulent phage growth. PLoS One. 2(8):e799.
   PubMed Web of Science ®Google Scholar
• Danelishvili L, Young LS, Bermudez LE. 2006. In vivo efficacy of phage therapy for Mycobacterium avium infection as delivered by a nonvirulent mycobacterium. Microb Drug Resist. 12(1):1–6.
   PubMed Web of Science ®Google Scholar
• Dedrick RM, Guerrero-Bustamante CA, Garlena RA, Russell DA, Ford K, Harris K, Gilmour KC, Soothill J, Jacobs-Sera D, Schooley RT, et al. 2019. Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. Nat Med. 25(5):730–733.
   PubMed Web of Science ®Google Scholar
• Doore SM, Schrad JR, Dean WF, Dover JA, Parent KN. 2018. Phages Isolated during a dysentery outbreak reveal uncommon structures and broad species diversity. J Virol. 92(8):e02117-17.
   PubMed Web of Science ®Google Scholar
• Dor-On E, Solomon B. 2015. Targeting glioblastoma via intranasal administration of Ff bacteriophages. Front Microbiol. 6:530.
   PubMed Web of Science ®Google Scholar
• Duerr DM, White SJ, Schluesener HJ. 2004. Identification of peptide sequences that induce the transport of phage across the gastrointestinal mucosal barrier. J Virol Methods. 116(2):177–180.
   PubMed Web of Science ®Google Scholar
• Dupuis M-È, Villion M, Magadán AH, Moineau S. 2013. CRISPR-Cas and restriction-modification systems are compatible and increase phage resistance. Nat Commun. 4:2087.
   PubMed Web of Science ®Google Scholar
• Enikeeva FN, Severinov KV, Gelfand MS. 2010. Restriction-modification systems and bacteriophage invasion: who wins? J Theor Biol. 266(4):550–559.
   PubMed Web of Science ®Google Scholar
• Fang FC. 2011. Antimicrobial actions of reactive oxygen species. mBio. 2(5):e00141–11.
   PubMed Web of Science ®Google Scholar
• Faruque SM, Chowdhury N, Khan R, Hasan MR, Nahar J, Islam MJ, Yamasaki S, Ghosh AN, Nair GB, Sack DA, et al. 2003. Shigella dysenteriae type 1-specific bacteriophage from environmental waters in Bangladesh. Appl Environ Microbiol. 69(12):7028–7031.
   PubMed Web of Science ®Google Scholar
• Fenaroli F, Robertson JD, Scarpa E, Gouveia VM, Di Guglielmo C, De Pace C, Elks PM, Poma A, Evangelopoulos D, Canseco JO, et al. 2020. Polymersomes eradicating intracellular bacteria. ACS Nano. 14(7):8287–8298.
   PubMed Web of Science ®Google Scholar
• Fenton OS, Olafson KN, Pillai PS, Mitchell MJ, Langer R. 2018. Advances in biomaterials for drug delivery. Adv Mater. 30(29):e1705328.
   Web of Science ®Google Scholar
• Fisher RA, Gollan B, Helaine S. 2017. Persistent bacterial infections and persister cells. Nat Rev Microbiol. 15(8):453–464.
   PubMed Web of Science ®Google Scholar
• Ford ME, Sarkis GJ, Belanger AE, Hendrix RW, Hatfull GF. 1998. Genome structure of mycobacteriophage D29: implications for phage evolution. J Mol Biol. 279(1):143–164.
   PubMed Web of Science ®Google Scholar
• Ford ME, Stenstrom C, Hendrix RW, Hatfull GF. 1998. Mycobacteriophage TM4: genome structure and gene expression. Tuber Lung Dis. 79(2):63–73.
   PubMedGoogle Scholar
• Forti F, Roach DR, Cafora M, Pasini ME, Horner DS, Fiscarelli EV, Rossitto M, Cariani L, Briani F, Debarbieux L, et al. 2018. Design of a broad-range bacteriophage cocktail that reduces Pseudomonas aeruginosa biofilms and treats acute infections in two animal models. Antimicrob Agents Chemother. 62(6):e02573-17.
   PubMed Web of Science ®Google Scholar
• Fraunholz M, Sinha B. 2012. Intracellular Staphylococcus aureus: live-in and let die. Front Cell Infect Microbiol. 2:43.
   PubMed Web of Science ®Google Scholar
• Freeman EC, Weiland LM, Meng WS. 2013. Modeling the proton sponge hypothesis: examining proton sponge effectiveness for enhancing intracellular gene delivery through multiscale modeling. J Biomater Sci Polym Ed. 24(4):398–416.
   PubMed Web of Science ®Google Scholar
• Fu D, Roufogalis BD. 2007. Actin disruption inhibits endosomal traffic of P-glycoprotein-EGFP and resistance to daunorubicin accumulation. Am J Physiol Cell Physiol. 292(4):C1543–C1552.
   PubMed Web of Science ®Google Scholar
• Fulgione A, Ianniello F, Papaianni M, Contaldi F, Sgamma T, Giannini C, Pastore S, Velotta R, Della Ventura B, Roveri N, et al. 2019. Biomimetic hydroxyapatite nanocrystals are an active carrier for Salmonella bacteriophages. Int J Nanomedicine. 14:2219–2232.
   PubMed Web of Science ®Google Scholar
• Gaillard JL, Berche P, Mounier J, Richard S, Sansonetti P. 1987. In vitro model of penetration and intracellular growth of Listeria monocytogenes in the human enterocyte-like cell line Caco-2. Infect Immun. 55(11):2822–2829.
   PubMed Web of Science ®Google Scholar
• Galan JE. 1994. Interactions of bacteria with non-phagocytic cells. Current Opinion in Immunology. 6(4):590–595.
   PubMed Web of Science ®Google Scholar
• Garai P, Berry L, Moussouni M, Bleves S, Blanc-Potard A-B. 2019. Killing from the inside: Intracellular role of T3SS in the fate of Pseudomonas aeruginosa within macrophages revealed by mgtC and oprF mutants. PLoS Pathog. 15(6):e1007812.
   PubMed Web of Science ®Google Scholar
• Garcia E, Elliott JM, Ramanculov E, Chain PSG, Chu MC, Molineux IJ. 2003. The genome sequence of Yersinia pestis bacteriophage phiA1122 reveals an intimate history with the coliphage T3 and T7 genomes. J Bacteriol. 185(17):5248–5262.
   PubMed Web of Science ®Google Scholar
• García P, Martínez B, Obeso JM, Lavigne R, Lurz R, Rodríguez A. 2009. Functional genomic analysis of two Staphylococcus aureus phages isolated from the dairy environment. Appl Environ Microbiol. 75(24):7663–7673.
   PubMed Web of Science ®Google Scholar
• Gestin M, Dowaidar M, Langel U. 2017. Uptake mechanism of cell-penetrating peptides. Adv Exp Med Biol. 1030:255–264.
   PubMed Web of Science ®Google Scholar
• Gordillo Altamirano FL, Barr JJ. 2019. Phage therapy in the postantibiotic era. Clin Microbiol Reviews. 32(2):e00066-18.
   PubMed Web of Science ®Google Scholar
• Gordillo Altamirano FL, Barr JJ. 2020. Unlocking the next generation of phage therapy: the key is in the receptors. Curr Opin Biotechnol. 68:115–123.
   PubMed Web of Science ®Google Scholar
• Górski A, Borysowski J, Miȩdzybrodzki R. 2020. Bacteriophage interactions with epithelial cells: therapeutic implications. Front Microbiol. 11(3580):631161.
   PubMedGoogle Scholar
• Grant SS, Hung DT. 2013. Persistent bacterial infections, antibiotic tolerance, and the oxidative stress response. Virulence. 4(4):273–283.
   PubMed Web of Science ®Google Scholar
• Greenwood DJ, Dos Santos MS, Huang S, Russell MRG, Collinson LM, MacRae JI, West A, Jiang H, Gutierrez MG. 2019. Subcellular antibiotic visualization reveals a dynamic drug reservoir in infected macrophages. Science. 364(6447):1279–1282.
   PubMed Web of Science ®Google Scholar
• Gu J, Liu X, Li Y, Han W, Lei L, Yang Y, Zhao H, Gao Y, Song J, Lu R, et al. 2012. A method for generation phage cocktail with great therapeutic potential. PLoS One. 7(3):e31698.
   PubMed Web of Science ®Google Scholar
• Guang-Han O, Leang-Chung C, Vellasamy KM, Mariappan V, Li-Yen C, Vadivelu J. 2016. Experimental phage therapy for Burkholderia pseudomallei infection. PLoS One. 11(7):e0158213.
   PubMed Web of Science ®Google Scholar
• Guenther S, Huwyler D, Richard S, Loessner MJ. 2009. Virulent bacteriophage for efficient biocontrol of Listeria monocytogenes in ready-to-eat foods. Appl Environ Microbiol. 75(1):93–100.
   PubMed Web of Science ®Google Scholar
• Haddad Kashani H, Schmelcher M, Sabzalipoor H, Seyed Hosseini E, Moniri R. 2017. Recombinant endolysins as potential therapeutics against antibiotic-resistant Staphylococcus aureus: current status of research and novel delivery strategies. Clin Microbiol Reviews. 31(1):e00071–17.
   PubMed Web of Science ®Google Scholar
• Helaine S, Cheverton AM, Watson KG, Faure LM, Matthews SA, Holden DW. 2014. Internalization of Salmonella by macrophages induces formation of nonreplicating persisters. Science. 343(6167):204–208.
   PubMed Web of Science ®Google Scholar
• Hodyra-Stefaniak K, Miernikiewicz P, Drapała J, Drab M, Jończyk-Matysiak E, Lecion D, Kaźmierczak Z, Beta W, Majewska J, Harhala M, et al. 2015. Mammalian host-versus-phage immune response determines phage fate in vivo. Sci Rep. 5:14802.
   PubMed Web of Science ®Google Scholar
• Hori M, Yonekura S-I, Nohmi T, Gruz P, Sugiyama H, Yonei S, Zhang-Akiyama Q-M. 2010. Error-prone translesion DNA synthesis by Escherichia coli DNA polymerase IV (DinB) on templates containing 1,2-dihydro-2-oxoadenine. J Nucleic Acids. 2010:807579.
   PubMedGoogle Scholar
• Hsia R, Ohayon H, Gounon P, Dautry-Varsat A, Bavoil PM. 2000. Phage infection of the obligate intracellular bacterium, Chlamydia psittaci strain guinea pig inclusion conjunctivitis. Microbes Infect. 2(7):761–772.
   PubMed Web of Science ®Google Scholar
• Hussain S, Joo J, Kang J, Kim B, Braun GB, She Z-G, Kim D, Mann AP, Mölder T, Teesalu T, et al. 2018. Antibiotic-loaded nanoparticles targeted to the site of infection enhance antibacterial efficacy. Nat Biomed Eng. 2(2):95–103.
   PubMed Web of Science ®Google Scholar
• Hybiske K, Stephens RS. 2007. Mechanisms of host cell exit by the intracellular bacterium Chlamydia. Proc Natl Acad Sci U S A. 104(27):11430–11435.
   PubMed Web of Science ®Google Scholar
• Ibarra JA, Steele-Mortimer O. 2009. Salmonella-the ultimate insider. Salmonella virulence factors that modulate intracellular survival. Cell Microbiol. 11(11):1579–1586.
   PubMed Web of Science ®Google Scholar
• Jamwal SV, Mehrotra P, Singh A, Siddiqui Z, Basu A, Rao KVS. 2016. Mycobacterial escape from macrophage phagosomes to the cytoplasm represents an alternate adaptation mechanism. Sci Rep. 6:23089.
   PubMed Web of Science ®Google Scholar
• Jault P, Leclerc T, Jennes S, Pirnay JP, Que Y-A, Resch G, Rousseau AF, Ravat F, Carsin H, Le Floch R, et al. 2019. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial. Lancet Infect Dis. 19(1):35–45.
   PubMed Web of Science ®Google Scholar
• Jensen VB, Harty JT, Jones BD. 1998. Interactions of the invasive pathogens Salmonella typhimurium, Listeria monocytogenes, and Shigella flexneri with M cells and murine Peyer's patches. Infect Immun. 66(8):3758–3766.
   PubMed Web of Science ®Google Scholar
• Jung L-s, Ding T, Ahn J. 2017. Evaluation of lytic bacteriophages for control of multidrug-resistant Salmonella typhimurium. Ann Clin Microbiol Antimicrob. 16(1):66.
   PubMedGoogle Scholar
• Kalapala YC, Sharma PR, Agarwal R. 2020. Antimycobacterial potential of mycobacteriophage under disease-mimicking conditions. Front Microbiol. 11:583661.
   PubMed Web of Science ®Google Scholar
• Kamaly N, Yameen B, Wu J, Farokhzad OC. 2016. Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release. Chem Rev. 116(4):2602–2663.
   PubMed Web of Science ®Google Scholar
• Kamaruzzaman NF, Kendall S, Good L. 2017. Targeting the hard to reach: challenges and novel strategies in the treatment of intracellular bacterial infections. Br J Pharmacol. 174(14):2225–2236.
   PubMed Web of Science ®Google Scholar
• Kaur S, Harjai K, Chhibber S. 2014. Bacteriophage-aided intracellular killing of engulfed methicillin-resistant Staphylococcus aureus (MRSA) by murine macrophages. Appl Microbiol Biotechnol. 98(10):4653–4661.
   PubMed Web of Science ®Google Scholar
• Kim A, Shin T-H, Shin S-M, Pham CD, Choi D-K, Kwon M-H, Kim Y-S. 2012. Cellular internalization mechanism and intracellular trafficking of filamentous M13 phages displaying a cell-penetrating transbody and TAT peptide. PLoS One. 7(12):e51813.
   PubMed Web of Science ®Google Scholar
• Kim H, Barroso M, Samanta R, Greenberger L, Sztul E. 1997. Experimentally induced changes in the endocytic traffic of P-glycoprotein alter drug resistance of cancer cells. Am J Physiol. 273(2 Pt 1):C687–C702.
   PubMedGoogle Scholar
• Kim K-P, Cha J-D, Jang E-H, Klumpp J, Hagens S, Hardt W-D, Lee K-Y, Loessner MJ. 2008. PEGylation of bacteriophages increases blood circulation time and reduces T-helper type 1 immune response. Microb Biotechnol. 1(3):247–257.
   PubMed Web of Science ®Google Scholar
• Kolenda C, Josse J, Medina M, Fevre C, Lustig S, Ferry T, Laurent F. 2019. Evaluation of the activity of a combination of three bacteriophages alone or in association with antibiotics on Staphylococcus aureus embedded in biofilm or internalized in osteoblasts. Antimicrob Agents Chemother. 64(3):e02231–19.
   Web of Science ®Google Scholar
• Kortright KE, Chan BK, Koff JL, Turner PE. 2019. Phage therapy: a renewed approach to combat antibiotic-resistant bacteria. Cell Host Microbe. 25(2):219–232.
   PubMed Web of Science ®Google Scholar
• Krut O, Bekeredjian-Ding I. 2018. Contribution of the immune response to phage therapy. J Immunol. 200(9):3037–3044.
   PubMed Web of Science ®Google Scholar
• Kumar Y, Cocchiaro J, Valdivia RH. 2006. The obligate intracellular pathogen Chlamydia trachomatis targets host lipid droplets. Curr Biol. 16(16):1646–1651.
   PubMed Web of Science ®Google Scholar
• Lapenkova MB, Smirnova NS, Rutkevich PN, Vladimirsky MA. 2018. Evaluation of the efficiency of lytic Mycobacteriophage D29 on the model of M. tuberculosis-infected macrophage RAW 264 cell line. Bull Exp Biol Med. 164(3):344–346.
   PubMed Web of Science ®Google Scholar
• Lee S, Kim MG, Lee HS, Heo S, Kwon M, Kim GBae. 2017. Isolation and characterization of listeria phages for control of growth of Listeria monocytogenes in Milk. Korean J Food Sci Anim Resour. 37(2):320–328.
   PubMedGoogle Scholar
• Lehti TA, Pajunen MI, Skog MS, Finne J. 2017. Internalization of a polysialic acid-binding Escherichia coli bacteriophage into eukaryotic neuroblastoma cells. Nat Commun. 8(1):1915.
   PubMedGoogle Scholar
• Leitner L, Sybesma W, Chanishvili N, Goderdzishvili M, Chkhotua A, Ujmajuridze A, Schneider MP, Sartori A, Mehnert U, Bachmann LM, et al. 2017. Bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomized, placebo-controlled, double-blind clinical trial. BMC Urol. 17(1):90.
   PubMed Web of Science ®Google Scholar
• Lemaire S, Tulkens PM, Van Bambeke F. 2011. Contrasting effects of acidic pH on the extracellular and intracellular activities of the anti-gram-positive fluoroquinolones moxifloxacin and delafloxacin against Staphylococcus aureus. Antimicrob Agents Chemother. 55(2):649–658.
   PubMed Web of Science ®Google Scholar
• Loh B, Gondil VS, Manohar P, Khan FM, Yang H, Leptihn S. 2020. Encapsulation and delivery of therapeutic phages. Appl Environ Microbiol. 87(5):01979–01920.
   Web of Science ®Google Scholar
• Lu TK, Collins JJ. 2007. Dispersing biofilms with engineered enzymatic bacteriophage. Proc Natl Acad Sci U S A. 104(27):11197–11202.
   PubMed Web of Science ®Google Scholar
• Ma Y, Pacan JC, Wang Q, Xu Y, Huang X, Korenevsky A, Sabour PM. 2008. Microencapsulation of bacteriophage Felix O1 into chitosan-alginate microspheres for oral delivery. Appl Environ Microbiol. 74(15):4799–4805.
   PubMed Web of Science ®Google Scholar
• Madani F, Lindberg S, Langel U, Futaki S, Gräslund A. 2011. Mechanisms of cellular uptake of cell-penetrating peptides. J Biophys. 2011:414729.
   PubMedGoogle Scholar
• Mahichi F, Synnott AJ, Yamamichi K, Osada T, Tanji Y. 2009. Site-specific recombination of T2 phage using IP008 long tail fiber genes provides a targeted method for expanding host range while retaining lytic activity. FEMS Microbiol Lett. 295(2):211–217.
   PubMed Web of Science ®Google Scholar
• Malik DJ, Sokolov IJ, Vinner GK, Mancuso F, Cinquerrui S, Vladisavljevic GT, Clokie MRJ, Garton NJ, Stapley AGF, Kirpichnikova A. 2017. Formulation, stabilisation and encapsulation of bacteriophage for phage therapy. Adv Colloid Interface Sci. 249:100–133.
   PubMed Web of Science ®Google Scholar
• Malik-Kale P, Winfree S, Steele-Mortimer O. 2012. The bimodal lifestyle of intracellular Salmonella in epithelial cells: replication in the cytosol obscures defects in vacuolar replication. PLoS One. 7(6):e38732.
   PubMed Web of Science ®Google Scholar
• Manning AJ, Kuehn MJ. 2011. Contribution of bacterial outer membrane vesicles to innate bacterial defense. BMC Microbiol. 11:258.
   PubMed Web of Science ®Google Scholar
• Matsubara T, Emoto W, Kawashiro K. 2007. A simple two-transition model for loss of infectivity of phages on exposure to organic solvent. Biomol Eng. 24(2):269–271.
   PubMedGoogle Scholar
• Mayer O, Jain P, Weisbrod TR, Biro D, Ho L, Jacobs-Sera D, Hatfull GF, Jacobs WR. 2016. Fluorescent reporter DS6A mycobacteriophages reveal unique variations in infectibility and phage production in mycobacteria. J Bacteriol. 198(23):3220–3232.
   PubMed Web of Science ®Google Scholar
• McClarty G. 1994. Chlamydiae and the biochemistry of intracellular parasitism. Trends Microbiol. 2(5):157–164.
   PubMedGoogle Scholar
• Melo LDR, Oliveira H, Pires DP, Dabrowska K, Azeredo J. 2020. Phage therapy efficacy: a review of the last 10 years of preclinical studies. Crit Rev Microbiol. 46(1):78–99.
   PubMed Web of Science ®Google Scholar
• Merabishvili M, Pirnay J-P, Verbeken G, Chanishvili N, Tediashvili M, Lashkhi N, Glonti T, Krylov V, Mast J, Van Parys L, et al. 2009. Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials. PLoS One. 4(3):e4944.
   PubMed Web of Science ®Google Scholar
• Michot J-M, Seral C, Van Bambeke F, Mingeot-Leclercq M-P, Tulkens PM. 2005. Influence of efflux transporters on the accumulation and efflux of four quinolones (ciprofloxacin, levofloxacin, garenoxacin, and moxifloxacin) in J774 macrophages. Antimicrob Agents Chemother. 49(6):2429–2437.
   PubMed Web of Science ®Google Scholar
• Mohamed A, Taha O, El-Sherif HM, Connerton PL, Hooton SPT, Bassim ND, Connerton IF, El-Shibiny A. 2020. Bacteriophage ZCSE2 is a potent antimicrobial against Salmonella enterica Serovars: ultrastructure, genomics and efficacy. Viruses. 12(4):424.
   Web of Science ®Google Scholar
• Mohan Raj JR, Karunasagar I. 2019. Phages amid antimicrobial resistance. Crit Rev Microbiol. 45(5–6):701–711.
   PubMed Web of Science ®Google Scholar
• Møller-Olsen C, Ho SFS, Shukla RD, Feher T, Sagona AP. 2018. Engineered K1F bacteriophages kill intracellular Escherichia coli K1 in human epithelial cells. Sci Rep. 8(1):17559.
   PubMedGoogle Scholar
• Møller-Olsen C, Ross T, Leppard KN, Foisor V, Smith C, Grammatopoulos DK, Sagona AP. 2020. Bacteriophage K1F targets Escherichia coli K1 in cerebral endothelial cells and influences the barrier function. Sci Rep. 10(1):8903.
   PubMed Web of Science ®Google Scholar
• Monsur KA, Rahman MA, Huq F, Islam MN, Northrup RS, Hirschhorn N. 1970. Effect of massive doses of bacteriophage on excretion of vibrios, duration of diarrhoea and output of stools in acute cases of cholera. Bull World Health Organ. 42(5):723–732.
   PubMed Web of Science ®Google Scholar
• Moons P, Faster D, Aertsen A. 2013. Lysogenic conversion and phage resistance development in phage exposed Escherichia coli biofilms. Viruses. 5(1):150–161.
   PubMed Web of Science ®Google Scholar
• Mortality GBD. 2016. Causes of Death C. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 388(10053):1459–1544.
   PubMed Web of Science ®Google Scholar
• Moulder JW. 1985. Comparative biology of intracellular parasitism. Microbiol Rev. 49(3):298–337.
   PubMedGoogle Scholar
• Nguyen S, Baker K, Padman BS, Patwa R, Dunstan RA, Weston TA, Schlosser K, Bailey B, Lithgow T, Lazarou M, et al. 2017. Bacteriophage transcytosis provides a mechanism to cross epithelial cell layers. mBio. 8(6):01874–01817.
   PubMed Web of Science ®Google Scholar
• Nichterlein T, Kretschmar M, Schadt A, Meyer A, Wildfeuer A, Laufen H, Hof H. 1998. Reduced intracellular activity of antibiotics against Listeria monocytogenes in multidrug resistant cells. Int J Antimicrob Agents. 10(2):119–125.
   PubMed Web of Science ®Google Scholar
• Nieth A, Verseux C, Barnert S, Süss R, Römer W. 2015. A first step toward liposome-mediated intracellular bacteriophage therapy. Expert Opin Drug Deliv. 12(9):1411–1424.
   PubMed Web of Science ®Google Scholar
• Nieth A, Verseux C, Römer W. 2015. A question of attire: dressing up bacteriophage therapy for the battle against antibiotic-resistant intracellular bacteria. Springer Science Reviews. 3(1):1–11.
   Google Scholar
• Nitta SK, Numata K. 2013. Biopolymer-based nanoparticles for drug/gene delivery and tissue engineering. Int J Mol Sci. 14(1):1629–1654.
   PubMed Web of Science ®Google Scholar
• Nobrega FL, Costa AR, Santos JF, Siliakus MF, van Lent JWM, Kengen SWM, Azeredo J, Kluskens LD. 2016. Genetically manipulated phages with improved pH resistance for oral administration in veterinary medicine. Sci Rep. 6(1):39235.
   PubMedGoogle Scholar
• Odenholt I, Gustafsson I, Löwdin E, Cars O. 2003. Suboptimal antibiotic dosage as a risk factor for selection of penicillin-resistant Streptococcus pneumoniae: in vitro kinetic model. Antimicrob Agents Chemother. 47(2):518–523.
   PubMed Web of Science ®Google Scholar
• Ong CT, Babalola CP, Nightingale CH, Nicolau DP. 2005. Penetration, efflux and intracellular activity of tigecycline in human polymorphonuclear neutrophils (PMNs). J Antimicrob Chemother. 56(3):498–501.
   PubMed Web of Science ®Google Scholar
• Ooi ML, Drilling AJ, Morales S, Fong S, Moraitis S, Macias-Valle L, Vreugde S, Psaltis AJ, Wormald P-J. 2019. Safety and tolerability of bacteriophage therapy for chronic rhinosinusitis due to Staphylococcus aureus. JAMA Otolaryngol Head Neck Surg. 145(8):723–729.
   PubMed Web of Science ®Google Scholar
• Otero J, García-Rodríguez A, Cano-Sarabia M, Maspoch D, Marcos R, Cortés P, Llagostera M. 2019. Biodistribution of liposome-encapsulated bacteriophages and their transcytosis during oral phage therapy. Front Microbiol. 10:689.
   PubMed Web of Science ®Google Scholar
• Patel JC, Galán JE. 2005. Manipulation of the host actin cytoskeleton by Salmonella-all in the name of entry. Curr Opin Microbiol. 8(1):10–15.
   PubMed Web of Science ®Google Scholar
• Pei Y, Mohamed MF, Seleem MN, Yeo Y. 2017. Particle engineering for intracellular delivery of vancomycin to methicillin-resistant Staphylococcus aureus (MRSA)-infected macrophages. J Control Release. 267:133–143.
   PubMed Web of Science ®Google Scholar
• Peng L, Chen B-w, Luo Y-a, Wang G-z. 2006. Effect of mycobacteriophage to intracellular mycobacteria in vitro. Chin Med J (Engl). 119(8):692–695.
   PubMed Web of Science ®Google Scholar
• Peng X, Jiang G, Liu W, Zhang Q, Qian W, Sun J. 2016. Characterization of differential pore-forming activities of ESAT-6 proteins from Mycobacterium tuberculosis and Mycobacterium smegmatis. FEBS Lett. 590(4):509–519.
   PubMed Web of Science ®Google Scholar
• Piuri M, Hatfull GF. 2006. A peptidoglycan hydrolase motif within the mycobacteriophage TM4 tape measure protein promotes efficient infection of stationary phase cells. Mol Microbiol. 62(6):1569–1585.
   PubMed Web of Science ®Google Scholar
• Pizarro-Cerdá J, Kühbacher A, Cossart P. 2012. Entry of Listeria monocytogenes in mammalian epithelial cells: an updated view. Cold Spring Harb Perspect Med. 2(11):a010009–a010009.
   PubMed Web of Science ®Google Scholar
• Poole K. 2005. Efflux-mediated antimicrobial resistance. J Antimicrob Chemother. 56(1):20–51.
   PubMed Web of Science ®Google Scholar
• Porter J, Anderson J, Carter L, Donjacour E, Paros M. 2016. In vitro evaluation of a novel bacteriophage cocktail as a preventative for bovine coliform mastitis. J Dairy Sci. 99(3):2053–2062.
   PubMed Web of Science ®Google Scholar
• Puapermpoonsiri U, Spencer J, van der Walle CF. 2009. A freeze-dried formulation of bacteriophage encapsulated in biodegradable microspheres. Eur J Pharm Biopharm. 72(1):26–33.
   PubMed Web of Science ®Google Scholar
• Ramón-García S, Martín C, Thompson CJ, Aínsa JA. 2009. Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth. Antimicrob Agents Chemother. 53(9):3675–3682.
   PubMed Web of Science ®Google Scholar
• Reyes-Robles T, Dillard RS, Cairns LS, Silva-Valenzuela CA, Housman M, Ali A, Wright ER, Camilli A. 2018. Vibrio cholerae outer membrane vesicles inhibit bacteriophage infection. J Bacteriol. 200(15):e00792–17.
   PubMed Web of Science ®Google Scholar
• Riley LW. 1995. Determinants of cell entry and intracellular survival of Mycobacterium tuberculosis. Trends Microbiol. 3(1):27–31. 1995/01/01/
   PubMedGoogle Scholar
• Rowe SE, Wagner NJ, Li L, Beam JE, Wilkinson AD, Radlinski LC, Zhang Q, Miao EA, Conlon BP. 2020. Reactive oxygen species induce antibiotic tolerance during systemic Staphylococcus aureus infection. Nat Microbiol. 5(2):282–290.
   PubMed Web of Science ®Google Scholar
• Sarker SA, Sultana S, Reuteler G, Moine D, Descombes P, Charton F, Bourdin G, McCallin S, Ngom-Bru C, Neville T, et al. 2016. Oral phage therapy of acute bacterial diarrhea with two coliphage preparations: a randomized trial in children from Bangladesh. EBioMedicine. 4:124–137.
   PubMed Web of Science ®Google Scholar
• Scholl D, Merril C. 2005. The genome of bacteriophage K1F, a T7-like phage that has acquired the ability to replicate on K1 strains of Escherichia coli. J Bacteriol. 187(24):8499–8503.
   PubMed Web of Science ®Google Scholar
• Seral C, Barcia-Macay M, Mingeot-Leclercq MP, Tulkens PM, Van Bambeke F. 2005. Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria monocytogenes and Staphylococcus aureus in J774 macrophages. J Antimicrob Chemother. 55(4):511–517.
   PubMed Web of Science ®Google Scholar
• Seral C, Carryn S, Tulkens PM, Van Bambeke F. 2003. Influence of P-glycoprotein and MRP efflux pump inhibitors on the intracellular activity of azithromycin and ciprofloxacin in macrophages infected by Listeria monocytogenes or Staphylococcus aureus. J Antimicrob Chemother. 51(5):1167–1173.
   PubMed Web of Science ®Google Scholar
• Seral C, Michot J-M, Chanteux H, Mingeot-Leclercq M-P, Tulkens PM, Van Bambeke F. 2003. Influence of P-glycoprotein inhibitors on accumulation of macrolides in J774 murine macrophages. Antimicrob Agents Chemother. 47(3):1047–1051.
   PubMed Web of Science ®Google Scholar
• Singla S, Harjai K, Katare OP, Chhibber S. 2016. Encapsulation of bacteriophage in liposome accentuates its entry in to macrophage and shields it from neutralizing antibodies. PLoS One. 11(4):e0153777.
   PubMed Web of Science ®Google Scholar
• Sinha B, Herrmann M. 2005. Mechanism and consequences of invasion of endothelial cells by Staphylococcus aureus. Thromb Haemost. 94(2):266–277.
   PubMed Web of Science ®Google Scholar
• Śliwa-Dominiak J, Suszyńska E, Pawlikowska M, Deptuła W. 2013. Chlamydia bacteriophages. Arch Microbiol. 195(10–11):765–771.
   PubMed Web of Science ®Google Scholar
• Sousa JAM, Rocha EPC. 2019. Environmental structure drives resistance to phages and antibiotics during phage therapy and to invading lysogens during colonisation. Sci Rep. 9(1):3149.
   PubMedGoogle Scholar
• Spooner R, Yilmaz O. 2011. The role of reactive-oxygen-species in microbial persistence and inflammation. Int J Mol Sci. 12(1):334–352.
   PubMed Web of Science ®Google Scholar
• Srivastava AS, Chauhan DP, Carrier E. 2004. In utero detection of T7 phage after systemic administration to pregnant mice. Biotechniques. 37(1):81–83.
   PubMed Web of Science ®Google Scholar
• Sukumaran SK, Shimada H, Prasadarao NV. 2003. Entry and intracellular replication of Escherichia coli K1 in macrophages require expression of outer membrane protein A. Infect Immun. 71(10):5951–5961.
   PubMed Web of Science ®Google Scholar
• Swift BMC, Gerrard ZE, Huxley JN, Rees CED. 2014. Factors affecting phage D29 infection: a tool to investigate different growth states of mycobacteria. PLoS One. 9(9):e106690.
   PubMed Web of Science ®Google Scholar
• Tagliaferri TL, Jansen M, Horz H-P. 2019. Fighting pathogenic bacteria on two fronts: phages and antibiotics as combined strategy. Front Cell Infect Microbiol. 9(22):22.
   PubMedGoogle Scholar
• Takeuchi I, Osada K, Azam AH, Asakawa H, Miyanaga K, Tanji Y. 2016. The presence of two receptor-binding proteins contributes to the wide host range of staphylococcal twort-like phages. Appl Environ Microbiol. 82(19):5763–5774.
   PubMed Web of Science ®Google Scholar
• Tang M, Pham P, Shen X, Taylor JS, O'Donnell M, Woodgate R, Goodman MF. 2000. Roles of E. coli DNA polymerases IV and V in lesion-targeted and untargeted SOS mutagenesis. Nature. 404(6781):1014–1018.
   PubMed Web of Science ®Google Scholar
• Tian Y, Wu M, Liu X, Liu Z, Zhou Q, Niu Z, Huang Y. 2015. Probing the endocytic pathways of the filamentous bacteriophage in live cells using ratiometric pH fluorescent indicator. Adv Healthc Mater. 4(3):413–419.
   PubMed Web of Science ®Google Scholar
• Toti US, Guru BR, Hali M, McPharlin CM, Wykes SM, Panyam J, Whittum-Hudson JA. 2011. Targeted delivery of antibiotics to intracellular chlamydial infections using PLGA nanoparticles. Biomaterials. 32(27):6606–6613.
   PubMed Web of Science ®Google Scholar
• Tran Van Nhieu G, Bourdet-Sicard R, Duménil G, Blocker A, Sansonetti PJ. 2000. Bacterial signals and cell responses during Shigella entry into epithelial cells. Cell Microbiol. 2(3):187–193.
   PubMed Web of Science ®Google Scholar
• Trastoy R, Manso T, Fernández-García L, Blasco L, Ambroa A, Pérez del Molino ML, Bou G, García-Contreras R, Wood TK, Tomás M. 2018. Mechanisms of bacterial tolerance and persistence in the gastrointestinal and respiratory environments. Clin Microbiol Reviews. 31(4):e00023-18.
   PubMed Web of Science ®Google Scholar
• Trigo G, Martins TG, Fraga AG, Longatto-Filho A, Castro AG, Azeredo J, Pedrosa J. 2013. Phage therapy is effective against infection by Mycobacterium ulcerans in a murine footpad model. PLoS Negl Trop Dis. 7(4):e2183.
   PubMed Web of Science ®Google Scholar
• United States of America clinical trial database. n.d. https://www.clinicaltrials.gov/.
   Google Scholar
• Van Belleghem J, Dąbrowska K, Vaneechoutte M, Barr J, Bollyky P. 2018. Interactions between bacteriophage, bacteria, and the mammalian immune system. Viruses. 11(1):10.
   Web of Science ®Google Scholar
• Van Nhieu GT, Isberg RR. 1991. The Yersinia pseudotuberculosis invasin protein and human fibronectin bind to mutually exclusive sites on the alpha 5 beta 1 integrin receptor. J Biol Chem. 266(36):24367–24375.
   PubMed Web of Science ®Google Scholar
• Vinner GK, Richards K, Leppanen M, et al. 2019. Microencapsulation of enteric bacteriophages in a pH-responsive solid oral dosage formulation using a scalable membrane emulsification process. Pharmaceutics. 11(9):475.
   Web of Science ®Google Scholar
• Watson BNJ, Vercoe RB, Salmond GPC, Westra ER, Staals RHJ, Fineran PC. 2019. Type I-F CRISPR-Cas resistance against virulent phages results in abortive infection and provides population-level immunity. Nat Commun. 10(1):5526.
   PubMedGoogle Scholar
• Wayne LG, Sohaskey CD. 2001. Nonreplicating persistence of mycobacterium tuberculosis. Annu Rev Microbiol. 55:139–163.
   PubMed Web of Science ®Google Scholar
• Wijagkanalan W, Kawakami S, Takenaga M, Igarashi R, Yamashita F, Hashida M. 2008. Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats. J Control Release. 125(2):121–130.
   PubMed Web of Science ®Google Scholar
• Wittebole X, De Roock S, Opal SM. 2014. A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens. Virulence. 5(1):226–235.
   PubMed Web of Science ®Google Scholar
• World Health Organization. 2019. Tuberculosis [Report]. WHO fact sheets. 14 October 2020. https://www.who.int/teams/global-tuberculosis-programme/tb-reports
   Google Scholar
• Xu H, Bao X, Wang Y, Xu Y, Deng B, Lu Y, Hou J. 2018. Engineering T7 bacteriophage as a potential DNA vaccine targeting delivery vector. Virol J. 15(1):49.
   PubMedGoogle Scholar
• Xue Y, Zhai S, Wang Z, Ji Y, Wang G, Wang T, Wang X, Xi H, Cai R, Zhao R, et al. 2020. The yersinia phage X1 administered orally efficiently protects a murine chronic enteritis model against Yersinia enterocolitica infection. Front Microbiol. 11:351.
   PubMed Web of Science ®Google Scholar
• Yang C, Krishnamurthy S, Liu J, Liu S, Lu X, Coady DJ, Cheng W, De Libero G, Singhal A, Hedrick JL, et al. 2016. Broad-spectrum antimicrobial star polycarbonates functionalized with mannose for targeting bacteria residing inside immune cells. Adv Healthc Mater. 5(11):1272–1281.
   PubMed Web of Science ®Google Scholar
• Yang Y, Shen W, Zhong Q, Chen Q, He X, Baker JL, Xiong K, Jin X, Wang J, Hu F, et al. 2020. Development of a bacteriophage cocktail to constrain the emergence of phage-resistant Pseudomonas aeruginosa. Front Microbiol. 11:327.
   PubMed Web of Science ®Google Scholar
• Yehl K, Lemire S, Yang AC, Ando H, Mimee M, Torres MDT, de la Fuente-Nunez C, Lu TK. 2019. Engineering phage host-range and suppressing bacterial resistance through phage Tail Fiber mutagenesis. Cell. 179(2):459–469.e9. 2019/10/03/
   PubMed Web of Science ®Google Scholar
• Żaczek M, Górski A, Skaradzińska A, Łusiak-Szelachowska M, Weber-Dąbrowska B. 2019. Phage penetration of eukaryotic cells: practical implications. Future Virology. 14(11):745–760.
   Web of Science ®Google Scholar
• Zhang H, Fouts DE, DePew J, Stevens RH. 2013. Genetic modifications to temperate Enterococcus faecalis phage Ef11 that abolish the establishment of lysogeny and sensitivity to repressor, and increase host range and productivity of lytic infection. Microbiology (Reading). 159(Pt 6):1023–1035.
   PubMedGoogle Scholar
• Zhang L, Sun L, Wei R, Gao Q, He T, Xu C, Liu X, Wang R. 2017. Intracellular Staphylococcus aureus control by virulent bacteriophages within MAC-T bovine mammary epithelial cells. Antimicrob Agents Chemother. 61(2):e01990–16.
   PubMed Web of Science ®Google Scholar
• Zhao X, Wu W, Qi Z, Cui Y, Yan Y, Guo Z, Wang Z, Wang H, Deng H, Xue Y, et al. 2011. The complete genome sequence and proteomics of Yersinia pestis phage Yep-phi. J Gen Virol. 92(Pt 1):216–221.
   PubMedGoogle Scholar